1887

n African Journal of Psychiatry - Lilly continues to invest in overall health of patients suffering from psychotic conditions - reached R1 million mark : product news

USD

 

Abstract

Recognising the need to further educate and assist people suffering from psychotic conditions such as schizophrenia and bipolar disorder to live healthier lives, leading pharmaceutical company, Eli Lilly, has been offering the "Lilly Wellness Plus" programme to patients since March 2006.

Loading

Article metrics loading...

/content/medjda2/11/2/EJC72661
2008-05-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error